Skip to main content
Contact Us
Subscribe
E-Edition
42°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
HEALTHCARE
(NY:
XLV
)
146.95
+0.78 (+0.53%)
Official Closing Price
Updated: 8:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about HEALTHCARE
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
3 High Dividend Socks to Replace Lower Savings Yields Ahead
April 09, 2024
Three stocks stand out as the most attractive dividend propositions, particularly now that savings yields may drop as a result of the Fed's rate cuts
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Stocks Falter Ahead Of Data-Rich Week, Tesla Rallies On 'Robotaxi' Push, Bitcoin Reclaims $71,500: What's Driving Markets Monday?
April 08, 2024
It’s a lackluster trading session on Wall Street, with the main indices experiencing slight declines as traders adopt a cautious stance ahead of a data-heavy week.
Via
Benzinga
S&P 500, Nasdaq 100 Eye Record Close As Magnificent 7 Rally, Bitcoin Rebounds: What's Driving Markets Thursday?
April 04, 2024
US equities rallied on Thursday as investors expected slower labor market growth and potential rate cuts. AI-related stocks and major indices all saw gains.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
XLV Made Reaction From The Blue Box
March 04, 2024
XLV is giving us wave (2) pull back that is unfolding as Double Three pattern. Pull back has already reached extreme zone from the peak.
Via
Talk Markets
Healthcare And Biotech Stocks Review: Q1 2024 Performance
April 01, 2024
We just had one of the best first quarters in recent market history since Q1 in 2019 when the market was up 13%. But changes in sector performance may be coming. The S&P 500 was up 10% showing a slight...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
EXCLUSIVE: Pharma's Cloud Revolution — A $60B Market By 2030 With 1 Stock To Watch
March 28, 2024
DiMarzio, VP & Portfolio Manager at Rockland Trust, highlights healthcare sector's potential for rebound & growth opportunities for investors.
Via
Benzinga
Tuesday Talk: Big-Tech Under Attack
March 26, 2024
On Thursday the Justice Dept. filed an antitrust suit against Apple. The suit joins two others already filed against Google. How much this will affect the market in the long run is up for grabs.
Via
Talk Markets
What Is An ETF For Dummies? Unlocking Strategic Insights
March 26, 2024
Via
Talk Markets
Topics
ETFs
Biotechnology And Healthcare, A Bit Of A Lull
March 25, 2024
Strong momentum of Tech and Chip stocks may be too good of a distraction for biotech investors.
Via
Talk Markets
Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
March 24, 2024
Novo Nordisk and Nvidia have teamed up to develop supercomputers, aiming to accelerate drug discovery development using advanced AI technologies.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Want $1 Million in Retirement? 9 ETFs to Buy Now and Hold for Decades.
March 24, 2024
Parking some of your dollars in high-performing sector ETFs may juice your portfolio's returns.
Via
The Motley Fool
Topics
ETFs
Bulls Stampede On Fed's Dovish Signal, Nasdaq 100 Hits New Record High, DOJ Sues Apple: What's Driving Markets Thursday?
March 21, 2024
Bulls are on fire in the aftermath of the Federal Reserve’s March policy meeting, igniting a rally in stocks across the board on Wall Street. The S&P 500 index surged above 5,250 points, continuing its...
Via
Benzinga
Topics
Economy
Lawsuit
Exposures
Financial
Interest Rates
Legal
Healthcare And Biotech Update With Market At 2024 Highs
March 20, 2024
The bull market is intact with technology Stocks dominating, but XLV is up 6.89%YTD.
Via
Talk Markets
Stocks Hold Steady Ahead Of Fed Meeting, Oil Eases, Bitcoin Rebounds: What's Driving Markets Wednesday?
March 20, 2024
It’s a quiet session on Wall Street Wednesday as investors remain on the sidelines, awaiting further clues on monetary policy front with the Federal Open Market Committee (FOMC) meeting scheduled for 2...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
March 11, 2024
Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23.
Via
Talk Markets
Health Care Workers Underpin US Jobs Growth In February
March 08, 2024
Hospitals and outpatient care account for bulk of health sector jobs.
Via
Benzinga
S&P 500 Index Closes At Record Heights, Reaches Most Overbought Conditions Since January 2020
March 07, 2024
S&P 500 index at 5,171 points, up 1% and hitting new highs. Week's rally is 17th in 19 weeks, with strong breadth and diverse sector performance.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
bluebird bio Stock Signals Potential to be a Multi-bagger
February 29, 2024
Driving a bargain of a short squeeze play, Bluebird Bio stock could soon announce what every investor is hoping to hear, here's what management could do
Via
MarketBeat
Topics
Economy
Exposures
Economy
Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect
February 27, 2024
Hedge funds are shifting towards stability and value by favoring the health care sector over booming tech stocks.
Via
Benzinga
Communications, Health Sectors Lead Rally In US Stocks In 2024
February 27, 2024
The strong year-to-date gain in the US stock market is broad based, led by shares in communications services and health care, based on a set of sector ETFs.
Via
Talk Markets
bluebird bio stock is ripe for a 400% institutional short squeeze
February 27, 2024
Bluebird Bio stock could be on the verge of a 400% pop on earnings, management has set the writing on the wall for institutional buying to trickle in
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Weekly Market Pulse: Artificial Intelligence?
February 26, 2024
The AI boom has pushed the stock market into one of its periodic flights of fancy when the future seems certain and imminent.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Nasdaq, S&P 500 Set for Mixed Open After Nvidia Euphoria: Analyst Picks Major Market Catalyst This Year If There Are No Rate Cuts
February 23, 2024
After the exuberance seen on Thursday, investors may assess whether it was an irrational one, and futures trading on Friday reflects edginess.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Top ETFs for Every Sector
February 22, 2024
Top ETFs for all 11 S&P 500 sectors.
Via
The Motley Fool
Topics
ETFs
Stocks
Exposures
US Equities
Healthcare Stocks Are Looking Better But What About Biotech?
February 20, 2024
Large cap biopharmacuiticals remain a core holding for growth and value despite political cross-currents on drug pricing.
Via
Talk Markets
Health Care Select Sector XLV Found Buyers At The Blue Box Area As Expected
February 18, 2024
In today’s article, we will look at the past performance of the one-hour chart for the Health Care Select Sector ETF XLV. The rally from the Jan. 25 low at $137.21 unfolded as a 5-wave impulse.
Via
Talk Markets
Topics
ETFs
Four Charts Every Trader Needs To See Today
February 17, 2024
As I’ve noted previously, the S&P 500 is quite extended above both its 10-week moving average (same as the 50-DMA) as well as the 40-week moving average (same as the 200-DMA).
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Market Correction Due: Stocks Are Running Out Of Reasons To Move Higher, Analyst Says
February 12, 2024
Stocks running out of reasons to move higher, market correction imminent. Internal indicators signal sell, could take S&P 500 back to 4,600.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
S&P 500 rockets to new highs as earnings beat estimates
February 09, 2024
The S&P 500 hits new highs as 10 of the 11 S&P sectors report positive Q4 earnings surprises. The tech and energy sectors are among the earnings leaders.
Via
MarketBeat
Topics
ETFs
Earnings
Stocks
Exposures
Financial
US Equities
Can financial, healthcare, energy stocks rise as rates stay high?
February 08, 2024
Sectors including financials, healthcare, utilities and energy outperform as interest rates remain high, but some of those industries face challenges in 2024.
Via
MarketBeat
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.